Theranos Lays Off 40% of Remaining Workers

Embattled firm is focusing on new device
By Rob Quinn,  Newser Staff
Posted Jan 7, 2017 9:05 AM CST
Theranos Cans Almost Half Its Remaining Workers
Elizabeth Holmes, founder and CEO of Theranos, speaks at the Fortune Global Forum in San Francisco, Monday, Nov. 2, 2015.   (AP Photo/Jeff Chiu)

In what Theranos is calling a a "further re-engineering of the company's operations," the company is firing around 40% of its employees just a few months after another huge round of job cuts. The firm, which is battling sanctions and numerous lawsuits over problems with its pinprick blood-testing technology, says 155 jobs have been cut and the remaining 220 employees will focus on developing its experimental miniLab tabletop blood-testing device, the Los Angeles Times reports. "This move allows Theranos to marshal its resources most efficiently and effectively," the company said in a statement. The company says it has also reshaped its management team to bring in more people with health-care industry experience, Bloomberg reports. (Read more Theranos stories.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.